Qianhui Wu

4.6k total citations · 3 hit papers
29 papers, 1.9k citations indexed

About

Qianhui Wu is a scholar working on Infectious Diseases, Modeling and Simulation and Health. According to data from OpenAlex, Qianhui Wu has authored 29 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 15 papers in Modeling and Simulation and 13 papers in Health. Recurrent topics in Qianhui Wu's work include SARS-CoV-2 and COVID-19 Research (21 papers), COVID-19 epidemiological studies (15 papers) and Vaccine Coverage and Hesitancy (13 papers). Qianhui Wu is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (21 papers), COVID-19 epidemiological studies (15 papers) and Vaccine Coverage and Hesitancy (13 papers). Qianhui Wu collaborates with scholars based in China, United States and South Korea. Qianhui Wu's co-authors include Hongjie Yu, Marco Ajelli, Yuxia Liang, Cécile Viboud, Stefano Merler, Juanjuan Zhang, Yan Wang, Maria Litvinova, Wei Wang and Alessandro Vespignani and has published in prestigious journals such as Science, Nature Medicine and Nature Communications.

In The Last Decade

Qianhui Wu

29 papers receiving 1.9k citations

Hit Papers

Changes in contact patter... 2020 2026 2022 2024 2020 2022 2021 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China
    2020 732 citations Juanjuan Zhang, Maria Litvinova et al. Science profile →
  2. Modeling transmission of SARS-CoV-2 Omicron in China
    2022 175 citations Jun Cai, Xiaowei Deng et al. Nature Medicine profile →
  3. Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials
    2021 173 citations Gang Zeng, Qianhui Wu et al. The Lancet Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qianhui Wu China 15 1.0k 906 443 286 285 29 1.9k
Affan Shoukat Canada 16 832 0.8× 885 1.0× 282 0.6× 336 1.2× 302 1.1× 31 1.8k
Chad R. Wells United States 18 751 0.7× 865 1.0× 253 0.6× 254 0.9× 288 1.0× 36 1.7k
Kevin van Zandvoort United Kingdom 14 634 0.6× 946 1.0× 253 0.6× 310 1.1× 364 1.3× 34 1.6k
Edouard Mathieu United Kingdom 6 799 0.8× 704 0.8× 543 1.2× 131 0.5× 294 1.0× 10 1.7k
Charlie Giattino United Kingdom 7 795 0.8× 697 0.8× 540 1.2× 125 0.4× 293 1.0× 9 1.7k
Joe Hasell United Kingdom 4 795 0.8× 697 0.8× 540 1.2× 124 0.4× 293 1.0× 5 1.6k
Ka Chun Chong Hong Kong 28 934 0.9× 827 0.9× 474 1.1× 562 2.0× 394 1.4× 205 3.1k
Ruian Ke United States 21 1.2k 1.2× 815 0.9× 196 0.4× 393 1.4× 218 0.8× 55 2.3k
Wira Winardi Indonesia 12 880 0.9× 429 0.5× 613 1.4× 169 0.6× 334 1.2× 20 1.9k
Esteban Ortiz-Ospina United Kingdom 10 795 0.8× 701 0.8× 546 1.2× 128 0.4× 343 1.2× 16 1.8k

Countries citing papers authored by Qianhui Wu

Since Specialization
Citations

This map shows the geographic impact of Qianhui Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qianhui Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qianhui Wu more than expected).

Fields of papers citing papers by Qianhui Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qianhui Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qianhui Wu. The network helps show where Qianhui Wu may publish in the future.

Co-authorship network of co-authors of Qianhui Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Qianhui Wu. A scholar is included among the top collaborators of Qianhui Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qianhui Wu. Qianhui Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zheng, Wen, Zhiyuan Chen, Xiaowei Deng, et al.. (2024). Global landscape of COVID-19 vaccination programmes for older adults: a descriptive study. The Lancet Healthy Longevity. 5(11). 100646–100646. 5 indexed citations
3.
Liu, Xiyan, Lixia Zheng, Jian Zhang, et al.. (2024). Adipose‐derived miRNAs as potential biomarkers for predicting adulthood obesity and its complications: A systematic review and bioinformatic analysis. Obesity Reviews. 25(7). e13748–e13748. 6 indexed citations
4.
Liu, Hengcong, Xiangyanyu Xu, Xiaowei Deng, et al.. (2024). Counterfactual analysis of the 2023 Omicron XBB wave in China. Infectious Disease Modelling. 9(1). 195–203. 4 indexed citations
5.
6.
7.
Ren, Lingshuang, Qianli Wang, Meng Xu, et al.. (2023). Cost and health‐related quality of life for children hospitalized with respiratory syncytial virus in Central China. Influenza and Other Respiratory Viruses. 17(8). e13180–e13180. 5 indexed citations
8.
Chen, Zhiyuan, Wen Zheng, Qianhui Wu, et al.. (2022). Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study. BMC Medicine. 20(1). 130–130. 27 indexed citations
9.
Cai, Jun, Xiaowei Deng, Juan Yang, et al.. (2022). Modeling transmission of SARS-CoV-2 Omicron in China. Nature Medicine. 28(7). 1468–1475. 175 indexed citations breakdown →
10.
Xin, Qianqian, Qianhui Wu, Xinhua Chen, et al.. (2022). Six-month follow-up of a booster dose of CoronaVac in two single-centre phase 2 clinical trials. Nature Communications. 13(1). 3100–3100. 18 indexed citations
11.
Liu, Hengcong, Juanjuan Zhang, Jun Cai, et al.. (2022). Investigating vaccine-induced immunity and its effect in mitigating SARS-CoV-2 epidemics in China. BMC Medicine. 20(1). 37–37. 12 indexed citations
12.
Chen, Xinhua, Zhiyuan Chen, Andrew S. Azman, et al.. (2021). Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Induced by Natural Infection or Vaccination: A Systematic Review and Pooled Analysis. Clinical Infectious Diseases. 74(4). 734–742. 67 indexed citations
13.
Zeng, Gang, Qianhui Wu, Hongxing Pan, et al.. (2021). Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials. The Lancet Infectious Diseases. 22(4). 483–495. 173 indexed citations breakdown →
14.
Yang, Juan, Valentina Marziano, Xiaowei Deng, et al.. (2021). Despite vaccination, China needs non-pharmaceutical interventions to prevent widespread outbreaks of COVID-19 in 2021. Nature Human Behaviour. 5(8). 1009–1020. 65 indexed citations
15.
Chen, Xinhua, Zhiyuan Chen, Andrew S. Azman, et al.. (2021). Neutralizing Antibodies Against SARS-CoV-2 Variants Induced by Natural Infection or Vaccination: A Systematic Review and Individual Data Meta-Analysis. SSRN Electronic Journal. 10 indexed citations
16.
Zhang, Juanjuan, Maria Litvinova, Yuxia Liang, et al.. (2020). Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China. Science. 368(6498). 1481–1486. 732 indexed citations breakdown →
17.
Wang, Wei, Qianhui Wu, Juan Yang, et al.. (2020). Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study. BMJ. 371. m4704–m4704. 128 indexed citations
18.
Qian, Mengcen, Qianhui Wu, Peng Wu, et al.. (2020). Anxiety levels, precautionary behaviours and public perceptions during the early phase of the COVID-19 outbreak in China: a population-based cross-sectional survey. BMJ Open. 10(10). e040910–e040910. 113 indexed citations
19.
Wu, Qianhui, Hongmin Chen, Shaokai Zhang, et al.. (2020). The economic burden of cervical cancer from diagnosis to one year after final discharge in Henan Province, China: A retrospective case series study. PLoS ONE. 15(5). e0232129–e0232129. 15 indexed citations
20.
Yang, Juan, Xinhua Chen, Xiaowei Deng, et al.. (2020). Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China. Nature Communications. 11(1). 5411–5411. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Affan Shoukat Breakdown of academic impact, for papers by Chad R. Wells Breakdown of academic impact, for papers by Kevin van Zandvoort Breakdown of academic impact, for papers by Edouard Mathieu Breakdown of academic impact, for papers by Charlie Giattino Breakdown of academic impact, for papers by Joe Hasell Breakdown of academic impact, for papers by Ka Chun Chong Breakdown of academic impact, for papers by Ruian Ke Breakdown of academic impact, for papers by Wira Winardi Breakdown of academic impact, for papers by Esteban Ortiz-Ospina
Rankless by CCL
2026